A traditional CRO,
in an ever-evolving world

Israel is recognized for rigorous clinical research

Reputation & Experience

Israel was among the world’s earliest adopters of a legal medical cannabis program and, as such, is recognized as the global leader in the study of the Cannabis Sativa plant. Either as a stand-alone or as part of a multi-center approach, we can implement clinical trials compliant with international standards including ICH GCP, The Clinical Trial Directive 2001/20/EU and the code of Federal Regulations (FDA 21 CFR).

Investigational Products

EndoCRO is proud of its close ties to some of Israel’s most experienced growers, formulators and manufacturers, and can supply the investigational products in adherence to the study protocol, GMP and local regulations.

Culture of Integrity

We are leaders in both research and the clinical study of cannabis medicine. Israel has more scientists and physicians per capita than anywhere in the world; we are unparalleled in our global understanding and application of every part of the medical cannabis chain.

World Class Specialists

Working with leading Principal Investigators and their teams, EndoCRO has a professional network of physicians in four of the largest hospitals in Israel. These centers have all participated in multi-site, multinational, GCP studies. Additionally, we offer multi-center studies in Israel, Canada, Australia and the United States.


A CRO that provides a complete range of contract development and contract clinical services including:

Asset 23

Market survey and analysis

Asset 24

Review of unmet clinical and market needs

Asset 25

Targeted list of partners (upstream and downstream)

Asset 26

Access to formulation and delivery systems partners

Asset 27

Pre-clinical and clinical study design and protocol development

Asset 28

Construction and management of project budgets

For more information contact us:

Close Menu